Johns Hopkins Researcher Develops mRNA Nanoparticles for T Cell Engineering

Manav Jain, a PhD student at Johns Hopkins, has developed specialized mRNA lipid nanoparticles designed for in vivo genetic engineering of T cells. This innovation aims to treat complex conditions such as cancer and autoimmune diseases. The research represents a significant advancement in biological materials and their application in therapeutic strategies, potentially offering new avenues for disease treatment.